Mitochondrial Fission in Nickel Nanoparticle-Induced Reproductive Toxicity: An In Vitro GC-1 Cell Study.
Hanyue ZhengGeyu LiangChunliu GuanLin LiuJiahui DongJinshun ZhaoMeng TangLu KongPublished in: Nanomaterials (Basel, Switzerland) (2024)
Reproductive disorders and declining fertility rates are significant public health concerns affecting birth rates and future populations. Male infertility, often due to spermatogenesis defects, may be linked to environmental pollutants like nickel nanoparticles (Ni NPs). Ni NPs are extensively utilized across different industries. Nevertheless, their potential adverse effects cannot be overlooked. Previous studies have linked the reproductive toxicity induced by Ni NPs with disturbances in mitochondrial function. Mitochondrial division/fusion dynamics are crucial to their proper function, yet little is known about how Ni NPs perturb these dynamics and whether such perturbation contributes to the impairment of the male reproductive system. Herein, we demonstrated that the exposure of Ni NPs to the mouse-derived spermatogonia cell line (GC-1 cells) triggered DRP1-mediated mitochondrial division and the enhanced impairment of mitochondria, consequently promoting mitochondria-dependent cell apoptosis. Notably, both the mitochondrial division inhibitor (Mdivi-1) and lentiviral-transfected cells with low expression of Dnm1l-DK in these cells could mitigate the toxic effects induced by Ni NPs, pointing to the potential role of mitochondrial dynamics in Ni NP-induced reproductive toxicity. Collectively, our work contributes to the understanding of the mechanisms by which Ni NPs can impact male reproductive function and identifies mitochondrial division as a potential target for intervention.
Keyphrases
- oxidative stress
- oxide nanoparticles
- induced apoptosis
- metal organic framework
- diabetic rats
- public health
- cell cycle arrest
- transition metal
- cell death
- human health
- stem cells
- randomized controlled trial
- cell proliferation
- signaling pathway
- poor prognosis
- risk assessment
- type diabetes
- mass spectrometry
- single cell
- dna methylation
- gene expression
- genome wide
- gene therapy
- metabolic syndrome
- gas chromatography
- carbon nanotubes
- pregnancy outcomes
- tandem mass spectrometry